Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,893.90 INR | -1.39% |
|
+4.72% | -14.33% |
05:46pm | Indian Stocks Fall Amid Tariff Talks With US | MT |
03:35pm | Concord Biotech Successfully Completes EU GMP Inspection at Dholka, India Unit | MT |
Main competitors
Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
---|---|---|---|---|---|---|---|
12Cr | 30.3% | 37.17% | 21.88% | 19.17% | -0.09x | ||
1.48TCr | 17.85% | 25.76% | 15.94% | 7.12% | 2.22x | ||
1.42TCr | 31.07% | 36.33% | 19.23% | 15.02% | -1.12x | ||
307.82Cr | 23.82% | 29.03% | 10.45% | 6.49% | 0.1x | ||
636.92Cr | 17.31% | 13.59% | 11.21% | 6.48% | 0.99x | ||
129.08Cr | -1% | -8.02% | -0.74% | -0.45% | -11.4x | ||
967.59Cr | 16.87% | 31.16% | 10.36% | 5.95% | 1.06x | ||
6.96Cr | 59.01% | 24.7% | 28.77% | 18.72% | -6.16x | ||
68Cr | -10.97% | -17.14% | -8.58% | -7.13% | 8.63x | ||
424.12Cr | 0.77% | 9.76% | 5.27% | 3.72% | -4.29x | ||
323.6Cr | -110.04% | -121.91% | -28.77% | -21.87% | 1.87x | ||
285.39Cr | 14.96% | 16.97% | 8.05% | 6.17% | -0.93x | ||
31Cr | 4.73% | 4.18% | 0.85% | - | -5.29x | ||
235.17Cr | 14.93% | 22.42% | 10.9% | 5.41% | 1.59x | ||
124.78Cr | 22.95% | 28.06% | 14.19% | 8.74% | 0.28x | ||
22Cr | -241.44% | -267.22% | 35.11% | -73.11% | -1.77x | ||
746.7Cr | 2.18% | 18.81% | 2.79% | 0.74% | 5.16x | ||
357.16Cr | 7.74% | 8.68% | 6.46% | 4.03% | 3.63x | ||
112.02Cr | 26.82% | 32.8% | 7.13% | 6.69% | -1.03x | ||
184.48Cr | 19.18% | 24.48% | 11.66% | - | - | ||
Average | 393.76Cr | -2.65% | -2.52% | 9.11% | 0.66% | -0.34x | |
Weighted average by Cap. | 711.56Cr | 9.65% | 11.09% | 11.23% | 4.72% | -0.20x |
- Stock Market
- Equities
- CONCORDBIO Stock
- Sector Concord Biotech Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition